Studies on the extraction of pumpkin components and their biological effects on blood glucose of diabetic mice

Journal of Food and Drug Analysis

Volumn 21, Issue 2, 2013, Pages 184-189

  Jin, Hui ^a   Zhang, Yong Jun ^a   Jiang, Jia Xin ^a   Zhu, Li Yun ^a   Chen, Ping ^a   Li, Jia ^a   Yao, Hui Yuan ^b  

^a CHINA JILIANG UNIVERSITY   (China)

^b JIANGNAN UNIVERSITY   (China)

Author keywords

Diabetes; Monosaccharide composition; Polysaccharide; Pumpkin

Indexed keywords

ALCOHOL; ALLOXAN; ANTIDIABETIC AGENT; ARABINOSE; GALACTOSE; GLUCOSE; PLANT EXTRACT; PUMPKIN CRUDE EXTRACT; RHAMNOSE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ISOLATION; DRUG PURIFICATION; FEMALE; GAS CHROMATOGRAPHY; GLUCOSE ASSAY; GLUCOSE BLOOD LEVEL; MALE; MOUSE; NONHUMAN; SQUASH;

MUS;

EID: 84881423776     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfda.2013.05.009     Document Type: Article

References (37)

1. Adams CC, Imran S, Wang S, et al. The hypoglycaemic effect of pumpkins as anti-diabetic and functional medicines. Food Res Int 2011;44:862-7.
2. Berger S, Strange P. Repaglinide, a novel and hypoglycemic agent in type 2 diabetes mellitus: a randomized, placebo-controlled, double-blind, fixed-dose study. Repaglinide Study Group. Diabetes 1998;47:A18.
3. Schwartz SL, Goldberg RB, Strange P. Repaglinide in type 2 diabetes: a randomized, double blind, placebo-controlled, dose-response study. Repaglinide Study Group. Diabetes 1998;47:A98.
4. Bayraktar M, Van Thiel DH, Adalar N. A comparison of acarbose versus metformin as an adjuvant therapy in sulfonylurea-treated NIDDM patients. Diabetes Care 1996;19:252-4.
5. Lebovitz HE. A new oral therapy for diabetes management: alpha-glucosidase inhibition with acarbose. Clin Diabetes 1995;13:99-103.
6. Maggs DG, Buchanan TA, Burant CF, et al. Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998;128:176-85. (Pubitemid 28078198)
7. Saltiel AR, Olefsky JM. Thiazolidinediones in the treatment of insulin resistance and type 2 diabetes. Diabetes 1996;45:1661-9. (Pubitemid 26398943)
8. Abraira C, Colwell JA, Nuttall FQ, et al. Veterans affairs cooperative study on glycemic control and complications in type 2 diabetes (VA CSDM). Result of the feasibility trial. Diabetes Care 1995;18:1113-23.
9. Edelman SV, Henry RR. Insulin therapy for normalizing glycosylated hemoglobin in type 2 diabetes: application, benefits, and risks. Diabetes Rev 1995;3:308-34.
10. Balakrishnan V, Prema P, Ravindran KC, et al. Ethnobotanical studies among villagers from Dharapuram taluk, Tamil Nadu. Indian Global J Pharmacol 2009;3:8-14.
11. Büyükbalci A, El SN. Determination of in vitro antidiabetic effects, antioxidant activities and phenol contents of some herbal teas. Plant Foods Hum Nutr 2008;63:27-33.
12. Jaiswal D, Rai PK, Watal G. Antidiabetic effect of Withania coagulans in experimental rats. Indian J Clin Biochem 2009;24:88-93.
13. Gurib-Fakim A, Subratty H, Narod F, et al. Biological activity from indigenous medicinal plants of Mauritius. Pure Appl Chem 2005;77:41-51. (Pubitemid 40326260)
14. Jiang ZG, Du QZ. Glucose-lowering activity of novel tetrasaccharide glyceroglycolipids from the fruits of Cucurbita moschata. Bioorg Med Chem Lett 2011;21:1001-3.
15. Yoshinari O, Sato H, Igarashi K. Anti-diabetic effects of pumpkin and its components, trigonelline and nicotinic acid, on goto-kakizaki rats. Biosci Biotechnol Biochem 2009;73:1033-41.
16. Wu T, Cao JS, Zhang YF. Comparison of antioxidant activities and endogenous hormone levels between bush and vine-type tropical pumpkin (Cucurbita moschata Duchesne). Sci Hortic 2008;116:27-33.
17. Jiang Y, Deng H, Yand YB, et al. Study on the antimicrobial and antiseptic action of pumpkin. J Chin Food Sci Tech 2005;10:37-9.
18. Yang LH. The 32 cases of pumpkin powder curing non-insulin dependent diabetes mellitus. Chin J Integr Med 1997;17:569-70.
19. Chen ZM. Study on reducing blood glucose and reducing blood pressure of pumpkin powder. Jiangxi J Trad Chin Med 1994;25:50-2.
20. Zhou HK. The comprehensive processing technology of pumpkins. Food Sci Chin 1991;12:59-62.
21. Longe OG, Farinu GO, Fetuga BL. Nutritional value of the fluted pumpkin (Tefaria accidentalis). J Agric Food Chem 1983;31:989-92.
22. Li QH, Fu CL, Rui YK, et al. Effects of protein-bound polysaccharide isolated from pumpkin on insulin in diabetic rats. Plant Foods Hum Nutr 2005;60:13-6.
23. Li QH, Tian Z, Cai TY. Study on the hypoglycemic action of pumpkin extract in diabetic rats. Acta Nutrimenta Sinica 2003;25:34-6.
24. Zhu HY, Chen X, Ren YL, et al. The protective effects of pumpkin polysaccharide on streptozotocin-induced islet injury. Chin J Hosp Pharm 2007;12:1647-9.
25. Navarini L, Gilli R, Gombac V. Polysaccharide from hot water extracts of roasted Coffea arabica beans: isolation and characterization. Carbohydr Polym 1999;40:71-81.
26. Dubois M, Gilles KA, Hamilton JK, et al. Colorimetric method for determination of sugars and related substances. Anal Chem 1956;28:350-6.
27. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt Biochem 1976;72:248-54.
28. Patricia S, Marie-Noelle G, Marie-Helene G, et al. Impaired pancreatic B cell function in the fetal GK rat. J Clin Invest 1998;101:899-904.
29. Dunn JS, Sheehan HL, McLetchie NGB. Necrosis of islets of Langerhans produced experimentally. Lancet 1943;1:484-7.
30. Ashok Kumar BS, Lakshman K, Nandeesh R, et al. In vitro alpha-amylase inhibition and in vivo antioxidant potential of Amaranthus spinosus in alloxan induced oxidative stress in diabetic rats. Saudi J Biol Sci 2011;18:1-5.
31. Elsner M, Tiedge M, Guldbakke B, et al. Importance of the GLUT2 glucose transporter for pancreatic beta cell toxicity of alloxan. Diabetologia 2002;45:1542-9. (Pubitemid 35352048)
32. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 2008;51:216-26.
33. Prince PSM, Menon VP, Gunasekharan G. Hypolipidaemic action of Tinospora cordifolia roots in alloxan diabetic rats. J Ethnopharmacol 1999;64:53-7. (Pubitemid 29059555)
34. Subramoniam A, Pushpagandan P, Rajasekharan S, et al. Effects of Artemisia pallens Wall on BG levels in normal and alloxan-induced diabetic rats. J Ethnopharmacol 1996;50:13-7. (Pubitemid 26028891)
35. Momose M, Abletshauser C, Neverve J, et al. Dysregulation of coronary microvascular reactivity in asymptomatic patients with type 2 diabetes mellitus. Eur J Nucl Med Mol Imaging 2002;29:1675-9.
36. Hu F, Li X, Zhao L, et al. Antidiabetic properties of purified polysaccharide from Hedysarum polybotrys. Can J Physiol Pharmacol 2010;88:64-72.
37. Zhao LY, Lan QJ, Huang ZC, et al. Antidiabetic effect of a newly identified component of Opuntia dillenii polysaccharides. Phytomedicine 2011;18:661-8.